Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001032733 | SCV001196040 | pathogenic | Ellis-van Creveld syndrome; Curry-Hall syndrome | 2019-03-11 | criteria provided, single submitter | clinical testing | This variant is a gross deletion of the genomic region encompassing exons 1-11 of the EVC gene, which includes the initiator codon. The 5' end of this event is unknown as it extends beyond the assayed region for this gene and therefore may encompass additional genes. The 3' boundary is likely confined to intron 11 of the EVC gene. This is expected to result in an absent or disrupted protein product. Isolated deletions of EVC exons 1-11 have not been reported in the literature. However, larger copy number events that include these exons in addition to other genes have been reported (PMID: 18454448, 25174843). Loss-of-function variants in EVC are known to be pathogenic (PMID: 23220543). For these reasons, this variant has been classified as Pathogenic. |